Skip to content

Seven Fleet Capital Management LP

Follow

13F filer, CIK 2092021, MOUNTAIN VIEW, CA

Seven Fleet Capital Management LP reported $511,733,165 across 85 holdings for the quarter ended 2026-09-30, in a 13F-HR filed 2026-11-16. Its ten largest share positions make up 68.9% of the portfolio.

Accepted , ingested 13F-HR 0001013594-26-001198

Period
2026-09-30
Reported value
$512M
Holdings
85
Top 10 weight
68.9%
New
20
Sold out
31

Largest buys vs the previous quarter

SecurityShares changeApprox. value
ENTXadded+6,671,390$19.4M
LQDAadded+339,672$10.3M
AVBPadded+204,567$6.19M
DMRAnew+288,439$6.14M
RVMDadded+22,559$4.63M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Largest sells vs the previous quarter

SecurityShares changeApprox. value
TNGXreduced-995,280-$24.8M
MIRMexited-110,393-$12.9M
DMRAexited-284,430-$7.4M
TARSreduced-68,537-$5.39M
ELVNreduced-103,429-$4.74M

Ranked by the share change valued at this quarter's implied price (value over shares in the 13F). A position sold out is valued at the previous quarter's price, its last report.

Holdings, Q3 2026

Share positions as resolved from 13F-HR 0001013594-26-001198, largest first. % of portfolio is the value over $511,733,165, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
CGONCG ONCOLOGY INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,515,151 shares; 2026Q1: 75,758 shares; 2026Q2: 1,886,236 shares; 2026Q3: 1,886,236 shares 1,886,236$134M26.13%0Timeline
TNGXTANGO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 215,172 shares; 2026Q1: 502,012 shares; 2026Q2: 3,228,144 shares; 2026Q3: 2,232,864 shares 2,232,864$55.7M10.89%-995,280Timeline
RVMDREVOLUTION MEDICINES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 65,800 shares; 2026Q1: 80,792 shares; 2026Q2: 242,029 shares; 2026Q3: 264,588 shares 264,588$54.3M10.61%+22,559Timeline
PHVSPHARVARIS N VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 55,342 shares; 2026Q1: 172,731 shares; 2026Q2: 774,501 shares; 2026Q3: 700,084 shares 700,084$22.2M4.34%-74,417Timeline
ENTXENTERA BIO LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 135,318 shares; 2026Q1: 205,542 shares; 2026Q2: 191,354 shares; 2026Q3: 6,862,744 shares 6,862,744$20M3.9%+6,671,390Timeline
LQDALIQUIDIA CORPORATIONQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 91,267 shares; 2026Q1: 187,876 shares; 2026Q2: 256,603 shares; 2026Q3: 596,275 shares 596,275$18M3.53%+339,672Timeline
AVBPARRIVENT BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 50,252 shares; 2026Q2: 246,606 shares; 2026Q3: 451,173 shares 451,173$13.7M2.67%+204,567Timeline
ELVNENLIVEN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 99,953 shares; 2026Q1: 164,030 shares; 2026Q2: 365,386 shares; 2026Q3: 261,957 shares 261,957$12M2.35%-103,429Timeline
AVTXAVALO THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 63,343 shares; 2026Q1: 213,819 shares; 2026Q2: 770,765 shares; 2026Q3: 772,660 shares 772,660$11.8M2.31%+1,895Timeline
XNCRXENCOR INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 109,554 shares; 2026Q1: 80,000 shares; 2026Q2: 368,305 shares; 2026Q3: 444,937 shares 444,937$11.1M2.17%+76,632Timeline
ROIVROIVANT SCIENCES LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 128,168 shares; 2026Q2: 220,126 shares; 2026Q3: 290,280 shares 290,280$10.6M2.07%+70,154Timeline
ABVXABIVAX SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 13,499 shares; 2026Q1: 43,052 shares; 2026Q2: 111,334 shares; 2026Q3: 99,274 shares 99,274$9.83M1.92%-12,060Timeline
ASMBASSEMBLY BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 73,762 shares; 2026Q1: 56,147 shares; 2026Q2: 433,147 shares; 2026Q3: 417,441 shares 417,441$9.81M1.92%-15,706Timeline
MANEVERADERMICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 80,000 shares; 2026Q3: 80,000 shares 80,000$9.7M1.9%0Timeline
PTGXPROTAGONIST THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 8,000 shares; 2026Q1: 4,000 shares; 2026Q2: 45,400 shares; 2026Q3: 45,659 shares 45,659$6.43M1.26%+259Timeline
DMRADAMORA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 288,439 shares 288,439$6.14M1.2%newTimeline
IPSCCENTURY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 2,947,826 shares; 2026Q2: 4,347,826 shares; 2026Q3: 4,421,739 shares 4,421,739$6.08M1.19%+73,913Timeline
EPRXEUPRAXIA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 433,515 shares; 2026Q2: 610,785 shares; 2026Q3: 572,267 shares 572,267$5.21M1.02%-38,518Timeline
AXSMAXSOME THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 12,955 shares; 2026Q1: 14,055 shares; 2026Q2: 28,826 shares; 2026Q3: 24,066 shares 24,066$4.44M0.87%-4,760Timeline
SGMTSAGIMET BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 403,545 shares; 2026Q3: 429,113 shares 429,113$4.24M0.83%+25,568Timeline
ZNTLZENTALIS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 110,000 shares; 2026Q2: 317,600 shares; 2026Q3: 1,504,231 shares 1,504,231$4.17M0.81%+1,186,631Timeline
DFTXDEFINIUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 99,887 shares; 2026Q2: 148,647 shares; 2026Q3: 108,647 shares 108,647$4.14M0.81%-40,000Timeline
DNTHDIANTHUS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 14,651 shares; 2026Q1: 54,258 shares; 2026Q2: 64,723 shares; 2026Q3: 46,432 shares 46,432$4.09M0.8%-18,291Timeline
SLNSILENCE THERAPEUTICS PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 147,600 shares; 2026Q1: 156,759 shares; 2026Q2: 60,107 shares; 2026Q3: 350,000 shares 350,000$3.83M0.75%+289,893Timeline
TARSTARSUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 4,500 shares; 2026Q1: 19,800 shares; 2026Q2: 117,067 shares; 2026Q3: 48,530 shares 48,530$3.81M0.75%-68,537Timeline
IMUXIMMUNIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 687,240 shares 687,240$3.66M0.72%newTimeline
TSHATAYSHA GENE THERAPIES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 167,223 shares; 2026Q1: 625,708 shares; 2026Q2: 1,504,400 shares; 2026Q3: 750,000 shares 750,000$3.65M0.71%-754,400Timeline
CYTKCYTOKINETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 10,335 shares; 2026Q1: 61,269 shares; 2026Q2: 118,240 shares; 2026Q3: 53,748 shares 53,748$3.54M0.69%-64,492Timeline
NERVMINERVA NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 248,476 shares; 2026Q2: 1,001,373 shares; 2026Q3: 1,001,373 shares 1,001,373$3.35M0.66%0Timeline
RLAYRELAY THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 73,000 shares; 2026Q1: 257,738 shares; 2026Q2: 178,222 shares; 2026Q3: 185,733 shares 185,733$3.35M0.66%+7,511Timeline
ZLABZAI LAB LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 77,858 shares; 2026Q2: 136,016 shares; 2026Q3: 118,395 shares 118,395$3.12M0.61%-17,621Timeline
PRAXPRAXIS PRECISION MEDICINES IQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 2,700 shares; 2026Q1: not reported; 2026Q2: 7,540 shares; 2026Q3: 10,489 shares 10,489$3.05M0.6%+2,949Timeline
CTMXCYTOMX THERAPEUTICS INC.Quarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 48,898 shares; 2026Q1: 371,398 shares; 2026Q2: 1,085,398 shares; 2026Q3: 1,085,398 shares 1,085,398$2.95M0.58%0Timeline
EDITEDITAS MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 1,330,500 shares; 2026Q3: 1,915,871 shares 1,915,871$2.94M0.58%+585,371Timeline
SABSSAB BIOTHERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 100,000 shares; 2026Q2: 736,077 shares; 2026Q3: 752,772 shares 752,772$2.39M0.47%+16,695Timeline
ASNDASCENDIS PHARMA A/SQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 11,869 shares; 2026Q3: 9,440 shares 9,440$2.15M0.42%-2,429Timeline
ANLADLAI NORTYE GROUP LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 113,207 shares; 2026Q3: 116,185 shares 116,185$1.86M0.36%+2,978Timeline
STROSUTRO BIOPHARMA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 159,118 shares; 2026Q3: 99,894 shares 99,894$1.61M0.31%-59,224Timeline
UTHRUNITED THERAPEUTICS CORP DELQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 1,300 shares; 2026Q1: 1,128 shares; 2026Q2: not reported; 2026Q3: 2,940 shares 2,940$1.59M0.31%newTimeline
IVAINVENTIVA SAQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 200,141 shares; 2026Q2: 200,141 shares; 2026Q3: 414,341 shares 414,341$1.53M0.3%+214,200Timeline
HRMYHARMONY BIOSCIENCES HLDGS INQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 37,900 shares 37,900$1.49M0.29%newTimeline
ANTXAN2 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 199,701 shares; 2026Q2: 208,946 shares; 2026Q3: 254,309 shares 254,309$1.35M0.26%+45,363Timeline
CLDXCELLDEX THERAPEUTICS INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 29,300 shares; 2026Q2: 86,664 shares; 2026Q3: 40,868 shares 40,868$1.32M0.26%-45,796Timeline
SMMTSUMMIT THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 73,300 shares; 2026Q3: 76,648 shares 76,648$1.3M0.25%+3,348Timeline
PCVXVAXCYTE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 25,365 shares; 2026Q1: 108,450 shares; 2026Q2: 29,800 shares; 2026Q3: 22,066 shares 22,066$1.26M0.25%-7,734Timeline
TCGXTCGX ACQUISITION CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 100,000 shares 100,000$1.25M0.24%newTimeline
CTNMCONTINEUM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 27,054 shares; 2026Q2: 60,541 shares; 2026Q3: 86,654 shares 86,654$1.16M0.23%+26,113Timeline
BHVNBIOHAVEN LTDQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 81,221 shares 81,221$1.08M0.21%newTimeline
SYRESPYRE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 19,690 shares; 2026Q2: 13,300 shares; 2026Q3: 11,611 shares 11,611$1.03M0.2%-1,689Timeline
INMINMED PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 1,069,519 shares 1,069,519$1M0.2%newTimeline
CRVSCORVUS PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 82,890 shares; 2026Q2: 82,890 shares; 2026Q3: 84,590 shares 84,590$974K0.19%+1,700Timeline
YARWYARROW BIOSCIENCE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 40,000 shares 40,000$901K0.18%newTimeline
CATXPERSPECTIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 379,082 shares; 2026Q2: 332,613 shares; 2026Q3: 296,087 shares 296,087$814K0.16%-36,526Timeline
IKTINHIBIKASE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 533,648 shares; 2026Q1: 325,600 shares; 2026Q2: 346,900 shares; 2026Q3: 358,460 shares 358,460$737K0.14%+11,560Timeline
OKURONKURE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 240,963 shares; 2026Q3: 240,963 shares 240,963$657K0.13%0Timeline
COGTCOGENT BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 214,099 shares; 2026Q1: 149,399 shares; 2026Q2: 147,510 shares; 2026Q3: 19,326 shares 19,326$619K0.12%-128,184Timeline
LONALEONABIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 127,951 shares; 2026Q1: 164,676 shares; 2026Q2: 154,153 shares; 2026Q3: 158,253 shares 158,253$565K0.11%+4,100Timeline
AMLXAMYLYX PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 11,571 shares; 2026Q1: 16,671 shares; 2026Q2: 14,540 shares; 2026Q3: 18,558 shares 18,558$540K0.11%+4,018Timeline
LSTALISATA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 371,411 shares 371,411$535K0.1%newTimeline
ERASERASCA INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 222,468 shares; 2026Q2: 308,007 shares; 2026Q3: 34,976 shares 34,976$513K0.1%-273,031Timeline
CCCCC4 THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 57,076 shares; 2026Q2: 381,169 shares; 2026Q3: 140,000 shares 140,000$466K0.09%-241,169Timeline
AVLNAVALYN PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 14,710 shares 14,710$419K0.08%newTimeline
NGNENEUROGENE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: 22,060 shares; 2026Q3: 14,700 shares 14,700$409K0.08%-7,360Timeline
MBXMBX BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 18,200 shares; 2026Q1: not reported; 2026Q2: 6,000 shares; 2026Q3: 6,810 shares 6,810$399K0.08%+810Timeline
BEAMBEAM THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 9,537 shares; 2026Q1: 8,804 shares; 2026Q2: 8,804 shares; 2026Q3: 15,844 shares 15,844$387K0.08%+7,040Timeline
IRLAQUINCE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 11,989 shares 11,989$372K0.07%newTimeline
PALIPALISADE BIO INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 327,500 shares; 2026Q1: 213,100 shares; 2026Q2: 272,204 shares; 2026Q3: 272,204 shares 272,204$367K0.07%0Timeline
IMTXIMMATICS N.VQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 39,500 shares 39,500$347K0.07%newTimeline
DRUGBRIGHT MINDS BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 6,395 shares; 2026Q2: 6,395 shares; 2026Q3: 6,395 shares 6,395$319K0.06%0Timeline
GERNGERON CORPQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 777,880 shares; 2026Q1: 424,180 shares; 2026Q2: 1,057,228 shares; 2026Q3: 258,900 shares 258,900$318K0.06%-798,328Timeline
OBXOBSIDIAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 23,077 shares 23,077$317K0.06%newTimeline
IDYAIDEAYA BIOSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 86,283 shares; 2026Q2: 37,865 shares; 2026Q3: 7,950 shares 7,950$305K0.06%-29,915Timeline
FTHFAETH THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 10,204 shares 10,204$303K0.06%newTimeline
TECXTECTONIC THERAPEUTIC INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 12,000 shares 12,000$279K0.05%newTimeline
IRONDISC MEDICINE INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 3,231 shares; 2026Q2: not reported; 2026Q3: 4,100 shares 4,100$268K0.05%newTimeline
ABEOABEONA THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 48,745 shares 48,745$256K0.05%newTimeline
UNCYUNICYCIVE THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 55,700 shares; 2026Q2: 103,400 shares; 2026Q3: 51,700 shares 51,700$243K0.05%-51,700Timeline
ACRSACLARIS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 107,419 shares; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 44,200 shares 44,200$232K0.05%newTimeline
CMPXCOMPASS THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 568,747 shares; 2026Q1: 516,972 shares; 2026Q2: 233,066 shares; 2026Q3: 193,034 shares 193,034$201K0.04%-40,032Timeline
INOINOVIO PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 137,100 shares 137,100$167K0.03%newTimeline
PRTAPROTHENA CORP PLCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: 43,300 shares; 2026Q1: 43,300 shares; 2026Q2: 43,300 shares; 2026Q3: 16,000 shares 16,000$134K0.03%-27,300Timeline
PMNPROMIS NEUROSCIENCES INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 10,600 shares; 2026Q2: 10,600 shares; 2026Q3: 10,600 shares 10,600$115K0.02%0Timeline
LPCNLIPOCINE INC NEWQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 124,942 shares; 2026Q2: 78,842 shares; 2026Q3: 34,161 shares 34,161$75.2K0.01%-44,681Timeline
IRDOPUS GENETICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: 134,242 shares; 2026Q2: 143,137 shares; 2026Q3: 10,000 shares 10,000$48.4K0.01%-133,137Timeline
PCSAPROCESSA PHARMACEUTICALS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2024Q4: not loaded; 2025Q1: not loaded; 2025Q2: not loaded; 2025Q3: not loaded; 2025Q4: not reported; 2026Q1: not reported; 2026Q2: not reported; 2026Q3: 18,300 shares 18,300$30K0.01%newTimeline

Sold out in Q3 2026

Positions in the previous quarter's report that this quarter's report no longer lists.

SecurityShares beforeValue beforeType
MIRMMIRUM PHARMACEUTICALS INC110,393$12.9Mshares
DMRADAMORA THERAPEUTICS INC284,430$7.4Mshares
MDGLMADRIGAL PHARMACEUTICALS INC4,973$2.67Mshares
RLMDRELMADA THERAPEUTICS INC348,265$2.41Mshares
AGIOAGIOS PHARMACEUTICALS INC56,900$2.11Mshares
XENEXENON PHARMACEUTICALS INC33,300$2.08Mshares
SVRASAVARA INC309,103$1.9Mshares
CELCCELCUITY INC16,252$1.7Mshares
SNDXSYNDAX PHARMACEUTICALS INC77,930$1.65Mshares
GPCRSTRUCTURE THERAPEUTICS INC26,800$1.44Mshares
ALKSALKERMES PLC23,285$1.22Mshares
TRVITREVI THERAPEUTICS INC45,598$833Kshares
VYGRVOYAGER THERAPEUTICS INC230,406$772Kshares
ENGNENGENE THERAPEUTICS INC411,065$711Kshares
LRMRLARIMAR THERAPEUTICS INC230,921$704Kshares
IHIISHARES TR13,800$682Kshares
KRYSKRYSTAL BIOTECH INC1,774$659Kshares
EOLSEVOLUS INC78,057$542Kshares
BCRXBIOCRYST PHARMACEUTICALS INC51,024$510Kshares
GLUEMONTE ROSA THERAPEUTICS INC16,800$407Kshares
OLMAOLEMA PHARMACEUTICALS INC31,476$394Kshares
MISTMILESTONE PHARMACEUTICALS IN270,233$362Kshares
CUECUE BIOPHARMA INC10,702$338Kshares
AZNASTRAZENECA PLC1,400$265Kshares
STOKSTOKE THERAPEUTICS INC7,745$255Kshares
VKTXVIKING THERAPEUTICS INC7,404$252Kshares
CRBPCORBUS PHARMACEUTICALS HLDGS21,432$201Kshares
WVEWAVE LIFE SCIENCES LTD19,048$99.8Kshares
PMVPPMV PHARMACEUTICALS INC53,569$71.8Kshares
FULCFULCRUM THERAPEUTICS INC18,089$66.2Kshares
QUREUNIQURE NV338$15.3Kshares

How Q3 2026 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001013594-26-001198 base2026-11-16